Physician response to COVID-19-driven telehealth flexibility for opioid use disorder.
Am J Manag Care
; 28(9): 456-463, 2022 Sep.
Article
in English
| MEDLINE | ID: covidwho-2040694
ABSTRACT
OBJECTIVES:
To learn how preferences and practices regarding telehealth have evolved during the COVID-19 pandemic for physicians who provide opioid use disorder (OUD) treatment. STUDYDESIGN:
Publicly registered physicians who provide OUD treatment were surveyed on their current and retrospective use of telehealth and how their perception of telehealth effectiveness and policy preferences have changed during the COVID-19 pandemic as telehealth regulations were loosened throughout the country.METHODS:
The primary survey data were collected in July 2020 leveraging administrative contact information for the population of publicly listed buprenorphine-prescribing physicians in the United States. A total of 1141 physicians received the survey and consented to participate.RESULTS:
Many surveyed physicians used telehealth for the first time during the early COVID-19 era (29% pre-COVID-19 use rate increased to 66%). Most respondents found telehealth to be more effective than expected (54% vs 16% who found it less effective), 85% were in favor of the temporary telehealth flexibility being permanently extended, and 77% would be likely to use telehealth after the COVID-19 pandemic, regulations permitting. Imputation exercises that leverage the linked survey and administrative data suggest that the findings are unlikely to be driven by nonrandom survey participation.CONCLUSIONS:
Physicians were asked about their OUD telehealth policy preferences. Findings suggest that the COVID-19 pandemic increased physician respondent use of telehealth technology, and this has positively shifted their perceptions of effectiveness. Respondents overwhelmingly report interest in post-COVID-19 pandemic telehealth use and support for proposed legislation to loosen telehealth restrictions.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Physicians
/
Buprenorphine
/
Telemedicine
/
COVID-19
/
Opioid-Related Disorders
Type of study:
Observational study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Am J Manag Care
Journal subject:
Health Services
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS